Search Results - Vogelmeier CF

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany by Vogelmeier CF, Diesing J, Kossack N, Pignot M, Friedrich FW

    Published in International Journal of COPD (2021-08-01)
    Get full text
    Article


  2. 2

    Comorbidities and Cause of Death in COPD Patients Compared to Non-COPD Controls: An 8-year Observational Retrospective Healthcare Claims Database Cohort Study by Vogelmeier CF, Friedrich FW, Timpel P, Kossack N, Diesing J, Pignot M, Abram M, Gediga M, Halbach M

    Published in International Journal of COPD (2025-06-01)
    Get full text
    Article


  3. 3

    Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort by Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A, Vogelmeier CF, Watz H

    Published in International Journal of COPD (2018-09-01)
    Get full text
    Article


  4. 4

    The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis by Veith M, Tüffers J, Peychev E, Klemmer A, Kotke V, Janciauskiene S, Wilhelm S, Bals R, Koczulla AR, Vogelmeier CF, Greulich T

    Published in International Journal of COPD (2020-11-01)
    Get full text
    Article


  5. 5

    Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study by Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, Compton C, Noorduyn SG, Ismaila AS, Requena G

    Published in International Journal of COPD (2024-08-01)
    Get full text
    Article


  6. 6

    The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort by Wacker ME, Kitzing K, Jörres RA, Leidl R, Schulz H, Karrasch S, Karch A, Koch A, Vogelmeier CF, Holle R

    Published in International Journal of COPD (2017-12-01)
    Get full text
    Article


  7. 7

    Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET by Alter P, Kahnert K, Trudzinski FC, Bals R, Watz H, Speicher T, Söhler S, Rabe KF, Wouters EFM, Vogelmeier CF, Jörres RA

    Published in International Journal of COPD (2024-12-01)
    Get full text
    Article


  8. 8

    Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology by Veith M, Klemmer A, Anton I, El Hamss R, Rapun N, Janciauskiene S, Kotke V, Herr C, Bals R, Vogelmeier CF, Greulich T

    Published in International Journal of COPD (2019-11-01)
    Get full text
    Article


  9. 9

    Personalized medicine for patients with COPD: where are we? by Franssen FME, Alter P, Bar N, Benedikter BJ, Iurato S, Maier D, Maxheim M, Roessler FK, Spruit MA, Vogelmeier CF, Wouters EFM, Schmeck B

    Published in International Journal of COPD (2019-07-01)
    Get full text
    Article


  10. 10

    Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET by Alter P, Stoleriu C, Kahnert K, Henke MO, Bals R, Trudzinski FC, Watz H, Speicher T, Söhler S, Welte T, Rabe KF, Wouters EFM, Vogelmeier CF, Jörres RA

    Published in International Journal of COPD (2023-12-01)
    Get full text
    Article


  11. 11

    Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action by Di Marco F, Shahaj O, Valipour A, Legrand B, Jommi C, Micheletto C, Vogelmeier CF, Freeman D, Kocks JWH, Alves L, Rubio MC, Peché R, Palkonen Snr S, Winders T, Roche N

    Published in International Journal of COPD (2025-05-01)
    Get full text
    Article


  12. 12

    Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipro... by Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G

    Published in Pragmatic and Observational Research (2024-01-01)
    Get full text
    Article


  13. 13

    Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET by Stoleriu MG, Pienn M, Joerres RA, Alter P, Fero T, Urschler M, Kovacs G, Olschewski H, Kauczor HU, Wielpütz M, Jobst B, Welte T, Behr J, Trudzinski FC, Bals R, Watz H, Vogelmeier CF, Biederer J, Kahnert K

    Published in International Journal of COPD (2024-07-01)
    Get full text
    Article


  14. 14

    Association of Patients’ Knowledge on the Disease and Its Management with Indicators of Disease Severity and Individual Characteristics in Patients with Chronic Obstructive P... by Fischer C, Siakavara M, Alter P, Vogelmeier CF, Speicher T, Pott H, Watz H, Bals R, Trudzinski F, Herth F, Ficker JH, Wagner M, Lange C, Stoycheva K, Randerath W, Behr J, Fähndrich S, Welte T, Pink I, Kahnert K, Seeger W, Kuhnert S, Gessler T, Adaskina N, Jörres RA

    Published in Patient Preference and Adherence (2024-12-01)
    Get full text
    Article


Search Tools: